As an Independent Consultant, specializing in the development and registration of New Chemical Entities (NCE) from pre-clinical, early to late stage development leading to registration state; I have consulted to both Pharmaceutical and Biotech companies, Contract Research Organizations (CROs), Universities and Financial Institutions.
Key areas in regulatory affairs and drug development include CNS (specifically in Parkinson disease, Alzheimer鈥檚 disease, depression, schizophrenia, and neuropathic pain), oncology, diabetes, rheumatology, anti-inflammatories and anti-infectives.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
